Indústrias
Showing 101–110 de 134 resultados
-
Physical Examination Market in China
In China, following a significant (17.6%) rise in 2019, physical examination market in terms of revenue declined dramatically (-11.2%), reaching 30 billion USD in 2020, de acordo com StrategyHelix.
-
Oral Health Services Market in China
In China, following a significant (11.9%) rise in 2019, oral health services market in terms of revenue declined dramatically (-16.7%), reaching 17,277 million USD in 2020, de acordo com StrategyHelix.
-
Ophthalmic Diagnosis Market in China
The ophthalmic diagnosis market in China was around 127 milhões em 2019, reached 134 milhões em 2020 (an increase of 5.1% year-on-year), de acordo com StrategyHelix’ análise.
-
Ophthalmic Medical Market in China
The ophthalmic medical market in China was around 18,184 million USD in 2019, reached 20,464 million USD in 2020 (an increase of 12.5% year-on-year), de acordo com StrategyHelix’ análise.
-
Peptide Market in China
A statistic by StrategyHelix indicates that the peptide market in China is anticipated to expand positively at a CAGR of 14.9% durante o período de previsão (2021-2027).
-
Minoxidil Market in China
The minoxidil market in China is projected to expand by a CAGR of 12% de 2021 through 2027.
-
Smart Healthcare Market in China
According to a statistic by StrategyHelix, the smart healthcare market in China is set to increase by US$ 5,744 milhões durante 2021-2027, crescendo em um CAGR de 12.2% durante o período de previsão.
-
Global Pharmaceutical R&D Spending Market
The global pharmaceutical R&D spending market is anticipated to expand positively at a CAGR of 6.8% durante o período de previsão (2021-2027), de acordo com StrategyHelix.
-
Global CRO (Contract Research Organization) Mercado
A statistic by StrategyHelix indicates that the global CRO (contract research organization) market is expected to increase at a CAGR of 9.9% até 2027.
-
CRO (Contract Research Organization) Mercado na China
A statistic by StrategyHelix indicates that the CRO (contract research organization) market in China is expected to increase by US$ 23,328 milhões de 2021 para 2027, obtendo um CAGR de 21.9% durante o período de previsão.